Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome

Clonidine, an α2-adrenergic receptor agonist, decreases circulating norepinephrine and epinephrine, attenuating sympathetic activity. Although catechol-O-methyltransferase (COMT) metabolizes catecholamines, main effectors of sympathetic function, COMT genetic variation effects on clonidine treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacogenomics J
Main Authors: Hall, Kathryn T., Kossowsky, Joe, Oberlander, Tim F., Kaptchuk, Ted J., Saul, J. Philip, Wyller, Vegard Bruun, Fagermoen, Even, Sulheim, Dag, Gjerstad, Johannes, Winger, Anette, Mukamal, Kenneth J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5028250/
https://ncbi.nlm.nih.gov/pubmed/27457818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2016.53
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados